Disease management. Getting out from under drug companies' shadows
Heimoff, S.
Managed Care 9(3): 39-40; 42-43
2000
ISSN/ISBN: 1062-3388 PMID: 11066212 Document Number: 523344
Document emailed within 1 workday
Related Documents
Yoshitomi, A.; Sato, A.; Tamura, R.; Suda, T.; Shichi, I.; Nakano, Y.; Iwata, M.; Hayakawa, H.; Chida, K.; Nakamura, S. 1992: A case of eosinophilic pneumonia with diffuse reticular shadows and scattered nodular shadows on chest X-ray film--comparison of findings of chest X-ray and lung histology Nihon Kyobu Shikkan Gakkai Zasshi 30(12): 2163-2167Chren, M.M.; Landefeld, C.S. 1991: Doctors, drug companies and gifts Rhode Island Medical Journal 74(12): 603-610
Charatan, F. 2001: Doctors say they are not influenced by drug companies' promotions Bmj 322(7294): 1081
Yamey, G. 2001: Pen "amnesty" for doctors who shun drug companies Bmj 322(7278): 69
2011: Targeting drug companies' bottom line Prescrire International 20(112): 25
Charatan, F. 2001: Drug companies defrauded Medicare of millions Bmj 323(7317): 828
Kaufman, J.A.; Williams, F.H. 1980: Francis H. Williams and the shadows of disease Connecticut Medicine 44(4): 229-232
2012: Key opinion leaders: used as a marketing tool by drug companies Prescrire International 21(128): 163-165
Watson, T.D.; Garvey, J.C. 1998: What you should know about dental practice management companies Texas Dental Journal 115(4): 11-13
Okotoni, O. 2004: Awareness and environmental management in oil companies in Nigeria Journal of Human Ecology 15(1): 13-17
Thomas, M.S. 1997: The future of physician practice management companies Healthcare Financial Management: Journal of the Healthcare Financial Management Association 51(8): 71-74
Meyer, A.; Pulle, M. 1998: Physician practice management companies: look before you leap Tennessee Medicine: Journal of the Tennessee Medical Association 91(2): 50-51
2014: Most profitable U.S. drug and biologic companies. Ranked by 2013 profit margin Modern healthcare Suppl: 30
1994: For U.S. drug companies' products sold in developing countries, labeling is often inadequate American Journal of Hospital Pharmacy 51(7): 875-876
Graham, J. 1985: Hospital management companies looking at leaner years--analysts Modern Healthcare 15(20): 106
2010: Drug companies monitor prescriptions and sales to fine-tune their marketing strategies Prescrire International 19(107): 140-141
Carlson, J. 2011: Data-mining law struck down. Supreme court sides with drug companies in Vermont ruling Modern Healthcare 41(26): 8-9
Derouesné, C.; Baudouin-Madec, V.; Kerromes, I. 1998: Non-drug management of Alzheimer's disease La Revue du Praticien 48(17): 1918-1922
Romano, M. 2002: 'It's like Enron'. FPA, other physician practice management companies hear death knell Modern Healthcare 32(7): 12
Lavastre, O.; Gunasekaran, A.; Spalanzani, A. 2012: Supply chain risk management in French companies : Decision Support Systems for Logistics and Supply Chain Management Decision Support Systems 52(4): 828-838